Compositions and methods for treating ocular disorders
US11219615B2 · kind B2 · utility
0Cited by
15References
23Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 8, 2021 |
| Grant date | Jan 11, 2022 |
| Priority date | — |
| Expiry date | Mar 8, 2041 |
Classification
- Technology area (CPC —)General
Abstract
The present disclosure is directed to compositions comprising oxymetazoline and methods of treating various eye disorders related to drooping eyelids, such as ptosis, in a subject comprising administering to the subject compositions comprising oxymetazoline.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.